Release of Cyclic Phosphatidic Acid from Gelatin-based Hydrogels Inhibit Colon Cancer Cell Growth and Migration
Microparticle and nanoparticle formulations are widely used to improve the bioavailability of low-solubility drugs and as vehicles for organ- and tissue-specific targeted drug delivery. We investigated the effect of a novel, controlled-release form of a bioactive lipid, cyclic phosphatidic acid (cPA...
Main Authors: | Tsukahara, Tamotsu, Murakami-Murofushi, Kimiko |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449289/ |
Similar Items
-
Cyclic phosphatidic acid relieves osteoarthritis symptoms
by: Gotoh, Mari, et al.
Published: (2014) -
Cyclic Phosphatidic Acid Stimulates cAMP Production and Inhibits Growth in Human Colon Cancer Cells
by: Tsukahara, Tamotsu, et al.
Published: (2013) -
Protection of Neuroblastoma Neuro2A Cells from Hypoxia-Induced Apoptosis by Cyclic Phosphatidic Acid (cPA)
by: Gotoh, Mari, et al.
Published: (2012) -
PPARγ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid
by: Tsukahara, Tamotsu
Published: (2013) -
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
by: Shinji Yamamoto, et al.
Published: (2017-07-01)